THIS NEW HOPE FOR WEIGHT MANAGEMENT ?

Experts are excitedly focused on retatrutide, a promising drug created by Eli Lilly, as a potential advance in body management. Distinct from many earlier approaches, retatrutide is a dual -action agonist targeting both GLP-1 and GIP, substances that affect appetite and blood glucose regulation